Studies involving sample source:T-cells
| Study ID | Study Title | Species | Institute |
|---|---|---|---|
| ST000140 | Cell Rinsing Solution Comparison | Human | University of Florida |
| ST000144 | Primary T Cell Baseline (Donor 5) - II | Human | University of Michigan |
| ST000145 | Primary T Cell Noxa Knockdown (Donor 8) | Human | University of Michigan |
| ST000146 | Noxa regulation of malate aspartate shuttle | Human | University of Michigan |
| ST000147 | 13C targeted metabolomics | Human | University of Michigan |
| ST000153 | Primary T Cell Noxa Knockdown (Donor 8)-II | Human | University of Michigan |
| ST000154 | Use of Aspartate Dehydrogenase by cancer cells | Human | University of Michigan |
| ST000178 | T cell metabolism during graft-versus-host disease (CAB 307)-PART I | Mouse | University of Michigan |
| ST000181 | T cell metabolism during graft-versus-host disease(CAB 311) | Mouse | University of Michigan |
| ST000370 | Primary T Cell Noxa Knockdown (Donor 8) III | Human | University of Michigan |
| ST000949 | Human NK vs T cell metabolism using 13C-Glucose tracer (part I) | Human | University of Kentucky |
| ST000950 | Human NK vs T cell metabolism using 13C-Glucose tracer with/out galactose (part II) | Human | University of Kentucky |
| ST000951 | Human NK vs T cell metabolism using 13C-Glucose tracer with/out oligomycin (part III) | Human | University of Kentucky |
| ST000952 | Human NK vs T cell metabolism using 13C-Glucose tracer with/out oligomycin and galactose (part IV) | Human | University of Kentucky |
| ST001476 | Design of Experiments for Maximizing T cell endpoints | Human | University of Georgia |
| ST001675 | Quantitative measurements of ceramides and glycosphingolipids in Th17 and iTreg cells (part-II) | Human | University of Turku |
| ST001676 | Lipidomic analysis of CD4+ T-cell subsets (Th1,Th2,Th17 and iTreg cells) (part I) | Human | University of Turku |
| ST001677 | Quantitative targeted measurements of sphingolipids in Th17 cells before and after the triple knockdown of SPTLC1,2,3 genes (SPT, de novo pathway: sphingolipid metabolism) (part-III) | Human | University of Turku |
| ST001678 | Quantitative measurements of sphingolipids in Th17 cells before and after the knockdown of UGCG gene (GCS pathway: sphingolipid metabolism) (part-IV) | Human | University of Turku |
| ST001679 | Quantitative measurements of sphingomyelins in Th17 cells before and after the knockdown of UGCG gene (GCS pathway: sphingolipid metabolism) (part-V) | Human | University of Turku |
| ST001986 | Fbxo7 promotes Cdk6 activity to inhibit PFKP and glycolysis in T cells | Mouse | University of Cambridge |
| ST002071 | Metabolic profiling of mouse CD27+ and CD27- gammadelta T cells | Mouse | University of Louisville |
| ST002185 | Lipidomic characterization of Jurkat-derived T cell line in which the chaperonin complex CCT has been partially silenced | Human | Centro Nacional de Investigaciones Cardiovasculares Carlos III |
| ST002486 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - mouse blood T-cell metabolomics | Mouse | University of Colorado Denver |
| ST002487 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - mouse spleen and lymph node T-cell metabolomics | Mouse | University of Colorado Denver |
| ST002488 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis - T-cell tracing supernatants | Mouse | University of Colorado Denver |
| ST002489 | Simultaneous targeting of PD-1 and IL2Rβγ with radiation therapy to inhibit pancreatic cancer growth and metastasis | Mouse | University of Colorado Denver |
| ST003091 | T cell Immune Escape in Blast Crisis Transformation of Chronic Myeloid Leukemia | Mouse | Translational Genomics Research Institute |
